Jerry Keybl

Jerry Keybl has a diverse work experience, starting in 2006 as a Research Assistant at the Massachusetts Institute of Technology. Jerry then worked as a Project Leader at The Boston Consulting Group from 2011 to 2014. In 2014, they joined Cabot Corporation as a Global Market Segment Manager, responsible for managing customer relationships and delivering growth in toners and coatings segments. In 2016, they moved to MilliporeSigma and held various roles, including Director of Strategic Initiatives and Senior Director of Cell & Gene Therapy. From 2020 to 2022, they served as a Board Member at the Alliance for Regenerative Medicine. Currently, they are employed at Avantor, where they started as VP of Biopharma Product Management and is now working as SVP of Biopharma Products & Strategy.

Jerry Keybl has a PhD in Chemical Engineering from the Massachusetts Institute of Technology. Jerry also has a BSE in Finance from The Wharton School and a BSE in Chemical Engineering from the University of Pennsylvania.